Ceribell receives FDA 510(k) clearance for qEEG trend analysis
Ceribell (CBLL) received FDA 510(k) clearance for quantitative EEG trending and amplitude-integrated EEG analysis.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Ceribell (CBLL) received FDA 510(k) clearance for quantitative EEG trending and amplitude-integrated EEG analysis.